196 related articles for article (PubMed ID: 25203520)
1. TMPRSS4: an emerging potential therapeutic target in cancer.
de Aberasturi AL; Calvo A
Br J Cancer; 2015 Jan; 112(1):4-8. PubMed ID: 25203520
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis.
Larzabal L; de Aberasturi AL; Redrado M; Rueda P; Rodriguez MJ; Bodegas ME; Montuenga LM; Calvo A
Br J Cancer; 2014 Feb; 110(3):764-74. PubMed ID: 24434435
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS4 induces cancer cell invasion through pro-uPA processing.
Min HJ; Lee MK; Lee JW; Kim S
Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TMPRSS4 mediated epithelial-mesenchymal transition is critically involved in antimetastatic effect of melatonin in colorectal cancers.
Oh BS; Im E; Lee HJ; Sim DY; Park JE; Park WY; Park Y; Koo J; Pak JN; Kim DH; Shim BS; Kim SH
Phytother Res; 2021 Aug; 35(8):4538-4546. PubMed ID: 34114707
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.
Jianwei Z; Qi L; Quanquan X; Tianen W; Qingwei W
Pathol Oncol Res; 2018 Apr; 24(2):251-257. PubMed ID: 28466252
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.
Kim S
Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
[TBL] [Abstract][Full Text] [Related]
10. The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer.
Luo ZY; Wang YY; Zhao ZS; Li B; Chen JF
PLoS One; 2013; 8(7):e70311. PubMed ID: 23922976
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.
Harbig A; Mernberger M; Bittel L; Pleschka S; Schughart K; Steinmetzer T; Stiewe T; Nist A; Böttcher-Friebertshäuser E
J Biol Chem; 2020 Aug; 295(33):11388-11407. PubMed ID: 32303635
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
14. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
[TBL] [Abstract][Full Text] [Related]
16. Role of TMPRSS4 during cancer progression.
Choi SY; Shin HC; Kim SY; Park YW
Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347
[TBL] [Abstract][Full Text] [Related]
17. Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial-mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT.
Xiao H; Zhang Z; Peng D; Wei C; Ma B
Anim Cells Syst (Seoul); 2021; 25(4):211-218. PubMed ID: 34408809
[TBL] [Abstract][Full Text] [Related]
18. The role of type II transmembrane serine protease-mediated signaling in cancer.
Tanabe LM; List K
FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane protease serine 4 promotes thyroid cancer proliferation via CREB phosphorylation.
Guan H; Liang W; Liu J; Wei G; Li H; Xiu L; Xiao H; Li Y
Thyroid; 2015 Jan; 25(1):85-94. PubMed ID: 25244400
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
